SCHEMBL12801198

SCHEMBL12801198

COc1cc(-c2ccnc(Cl)n2)cc(N)c1OC1CCOCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 4/20 0.42
PIK3CA P42336 5/20 0.41
JAK2 O60674 2/20 0.39
MTOR P42345 1/20 0.38
LRRK2 Q5S007 2/20 0.38
CACNB4 O00305 1/20 0.37
CACNA1A O00555 1/20 0.37
CACNA1G O43497 1/20 0.37
CACNG3 O60359 1/20 0.37
CACNA1F O60840 1/20 0.37
CACNA1H O95180 1/20 0.37
CACNB3 P54284 1/20 0.37
CACNA2D1 P54289 1/20 0.37
CACNG7 P62955 1/20 0.37
CACNA1B Q00975 1/20 0.37
CACNA1D Q01668 1/20 0.37
CACNB1 Q02641 1/20 0.37
CACNG1 Q06432 1/20 0.37
CACNB2 Q08289 1/20 0.37
CACNA1S Q13698 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1667558 0.85 TBK1 (0.48) SYKTBK1IKBKE
SCHEMBL12801501 0.81 KMO (0.47) PIK3CATBK1IKBKE
SCHEMBL12800881 0.79 PDE4B (0.46) PIK3CACACNB4CACNA1ACACNA1GCACNG3
SCHEMBL12801121 0.74 JAK2 (0.49) JAK2TBK1IKBKE
SCHEMBL12801073 0.72 JAK2 (0.69) SYKJAK2LRRK2TBK1IKBKE
SCHEMBL12801634 0.72 KMO (0.50) PIK3CAJAK2ALDH1A1EGFRCDK2
SCHEMBL12801199 0.71 KMT2A (0.40) SYKPIK3CACACNB4CACNA1ACACNA1G
SCHEMBL12801197 0.71 PDE4D (0.38) SYKPIK3CACACNB4CACNA1ACACNA1G
SCHEMBL1667272 0.70 TBK1 (0.64) TBK1IKBKE
SCHEMBL24904207 0.70 IKBKE (0.46) SYKPIK3CATBK1IKBKECDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011046970-A1 AMINO - PYRIMIDINE COMPOUNDS AS INHIBITORS OF TBKL AND/OR IKK EPSILON MYREXIS, INC. (US) 2011-04-21 WO disclosed